Mucocutaneous reactions to chemotherapy

Tosi, 1994, Drug-induced hair loss and hair growth. Incidence, management and avoidance. Drug Saf, 10, 310 Hood, 1986, Cutaneous side effects of cancer chemotherapy, Med Clin North Am, 70, 187, 10.1016/S0025-7125(16)30976-2 DeSpain, 1992, Dermatologic toxicity, 531 Pillans, 1995, Drug-associated alopecia, Int J Dermatol, 34, 149, 10.1111/j.1365-4362.1995.tb01556.x Baker, 1991, Busulphan/cyclophosphamide conditioning for bone marrow transplantation may lead to failure of hair regrowth, Bone Marrow Transplant, 7, 43 Fischer, 1997, The cancer chemotherapy handbook, 514 Fitzpatrick, 1987, Neutrophilic eccrine hidradenitis associated with induction chemotherapy, J Cutan Pathol, 14, 272, 10.1111/j.1600-0560.1987.tb00499.x Granai, 1991, The use of minoxidil to attempt to prevent alopecia during chemotherapy for gynecologic malignancies, Eur J Gynaecol Oncol, 12, 129 Rodriguez, 1994, Minoxidil (Mx) as a prophylaxis of doxorubicin-induced alopecia, Ann Oncol, 5, 769, 10.1093/oxfordjournals.annonc.a058986 Duvic, 1996, A randomized trial of minoxidil in chemotherapy-induced alopecia, J Am Acad Dermatol, 35, 74, 10.1016/S0190-9622(96)90500-9 Sonis, 1993, Oral complications of cancer therapy, 2385 Beran, 1996, Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia, Blood, 88, 2473, 10.1182/blood.V88.7.2473.bloodjournal8872473 Rowinsky, 1994, Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemia, J Clin Oncol, 12, 2193, 10.1200/JCO.1994.12.10.2193 Cunningham, 1995, ‘Tomudex’ (ZD1694): results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia, Eur J Cancer, 31A, 1945, 10.1016/0959-8049(95)00502-1 Bogner, 1994, Liposomal doxorubicin in the treatment of advanced AIDS-related Kaposi sarcoma, J Acquir Immune Defic Syndr, 7, 463 Uziely, 1995, Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies, J Clin Oncol, 13, 1777, 10.1200/JCO.1995.13.7.1777 Sole, 1995, Phase II trial of an all-oral regimen of tegafur and folinic acid in patients with previously treated metastatic breast cancer, Cancer, 75, 831, 10.1002/1097-0142(19950201)75:3<831::AID-CNCR2820750314>3.0.CO;2-S Basser, 1994, Comparative study of the pharmacokinetics and toxicity of high-dose epirubicin with or without dexrazoxane in patients with advanced malignancy, J Clin Oncol, 12, 1659, 10.1200/JCO.1994.12.8.1659 Muus, 1993, Idarubicin-related side effects in recipients of T-cell–depleted allogeneic bone marrow transplants are schedule dependent, Semin Oncol, 20, 47 Brincker, 1993, Acute mucocutaneous toxicity following high-dose hydroxyurea, Cancer Chemother Pharmacol, 32, 496, 10.1007/BF00685897 Comella, 1995, Dose-finding study of 5'-deoxy-5-fluorouridine in combination with fixed doses of cisplatin and L-folinic acid for the treatment of advanced or recurrent squamous cell carcinoma of the head and neck, Oncology, 52, 326, 10.1159/000227483 Vokes, 1993, Five-day infusional fluorodeoxyuridine with oral leucovorin and escalating doses of interferon alpha-2b: a phase I study, Cancer Chemother Pharmacol, 32, 347, 10.1007/BF00735917 Korstanje, 1995, Drug-induced mouth disorders, Clin Exp Dermatol, 20, 10, 10.1111/j.1365-2230.1995.tb01275.x Madeya, 1996, Oral complications from cancer therapy: part 2—nursing implications for assessment and treatment, Oncol Nurs Forum, 23, 808 Dumontet, 1994, Prevention of high dose L-PAM–induced mucositis by cryotherapy, Bone Marrow Transplant, 14, 492 Mahood, 1991, Inhibition of fluorouracil-induced stomatitis by oral cryotherapy, J Clin Oncol, 9, 449, 10.1200/JCO.1991.9.3.449 Loprinzi, 1995, Alleviation of cytotoxic therapy-induced normal tissue damage, Semin Oncol, 22, 95 Verdi, 1993, Cancer therapy and oral mucositis: an appraisal of drug prophylaxis, Drug Saf, 9, 185, 10.2165/00002018-199309030-00004 Peterson, 1992, Oral toxicity of chemotherapeutic agents, Semin Oncol, 19, 478 Heckler, 1989, Current thoughts on extravasation injuries, Clin Plast Surg, 16, 557, 10.1016/S0094-1298(20)31322-5 Davis, 1995, A flow sheet for follow-up after chemotherapy extravasation, Oncol Nurs Forum, 22, 979 Boyle, 1995, Vesicant extravasation: myths and realities, Oncol Nurs Forum, 22, 57 Herrington, 1997, Severe necrosis due to paclitaxel extravasation, Pharmacotherapy, 17, 163 Kerker, 1989, Chemotherapy-induced cutaneous reactions, Semin Dermatol, 8, 173 Bronner, 1983, Cutaneous complications of chemotherapeutic agents, J Am Acad Dermatol, 9, 645, 10.1016/S0190-9622(83)70177-5 Yokel, 1993, Mucocutaneous complications of antineoplastic therapy, 1795 Cox, 1986, Toxic erythema of palms and soles associated with high dose mercaptopurine chemotherapy, Arch Dermatol, 122, 1413, 10.1001/archderm.1986.01660240077020 Dorr, 1990, Antidotes to vesicant chemotherapy extravasations, Blood Rev, 4, 41, 10.1016/0268-960X(90)90015-K Bertelli, 1995, Prevention and management of extravasation of cytotoxic drugs, Drug Safety, 12, 245, 10.2165/00002018-199512040-00004 Mateu, 1994, Ifosfamide extravasation, Ann Pharmacother, 28, 1243, 10.1177/106002809402801106 Scuderi, 1994, Antitumor agents: extravasation, management, and surgical treatment, Ann Plast Surg, 32, 39, 10.1097/00000637-199401000-00008 San Angel, 1995, Current controversies in chemotherapy administration, J Intraven Nurs, 18, 16 Shenaq, 1996, Soft-tissue reconstruction following extravasation of chemotherapeutic agents, Surg Oncol Clin North Am, 5, 825, 10.1016/S1055-3207(18)30355-7 Rudolph, 1987, Etiology and treatment of chemotherapeutic agent extravasation injuries: a review, J Clin Oncol, 5, 1116, 10.1200/JCO.1987.5.7.1116 Banerjee, 1987, Cancer chemotherapy agent-induced perivenous extravasation injuries, Postgrad Med J, 63, 5, 10.1136/pgmj.63.735.5 Ajani, 1994, Taxol-induced soft-tissue injury secondary to extravasation: characterization by histopathology and clinical course, J Natl Cancer Inst, 86, 51, 10.1093/jnci/86.1.51 Bailey, 1997, Taxol extravasation: a case report, Can Oncol Nurs J, 7, 96, 10.5737/1181912x729697 Dini, 1995, Combined management in the treatment of epidoxorubicin extravasation: a case report, Support Care Cancer, 3, 150, 10.1007/BF00365857 Mateu, 1994, Delayed treatment of vindesine extravasation, Ann Pharmacother, 28, 967, 10.1177/106002809402800732 Tsavaris, 1990, Conservative approach to the treatment of chemotherapy-induced extravasation, J Dermatol Surg Oncol, 16, 519, 10.1111/j.1524-4725.1990.tb00073.x Dufresne, 1987, Skin necrosis from intravenously infused materials, Cutis, 39, 197 Beason, 1990, Antineoplastic vesicant extravasation, J Intraven Nurs, 13, 111 Shapiro, 1994, Paclitaxel-induced “recall” soft tissue injury occurring at the site of previous extravasation with subsequent intravenous treatment in a different limb, J Clin Oncol, 12, 2237, 10.1200/JCO.1994.12.10.2237 Cox, 1988, The management of cytotoxic-drug extravasation: guide-lines drawn up by a working party for the Clinical Oncological Society of Australia, Med J Aust, 148, 185, 10.5694/j.1326-5377.1988.tb112811.x Anonymous, 1993, Suggestions to prevent and manage chemotherapy extravasation, Oncology, 7, 42 Bertelli, 1995, Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study, J Clin Oncol, 13, 2851, 10.1200/JCO.1995.13.11.2851 Tsavaris, 1992, Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approach, Cancer Chemother Pharmacol, 30, 330, 10.1007/BF00686305 Zuehlke, 1974, Erythematous eruption of the palms and soles associated with mitotane therapy, Dermatologica, 148, 90, 10.1159/000251603 Baack, 1991, Chemotherapy-induced acral erythema, J Am Acad Dermatol, 24, 457, 10.1016/0190-9622(91)70073-B Bastida, 1997, Chemotherapy-induced acral erythema due to tegafur, Acta Derm Venereol (Stockh), 77, 72 Burgdorf, 1982, Peculiar acral erythema secondary to high-dose chemotherapy for acute myelogenous leukemia, Ann Intern Med, 97, 61, 10.7326/0003-4819-97-1-61 Cohen, 1993, Acral erythema: a clinical review, Cutis, 51, 175 Comandone, 1993, Palmar-plantar erythrodesestasia syndrome associated with 5-fluorouracil treatment, Anticancer Res, 13, 1781 Conroy, 1993, Simplified chronomodulated continuous infusion of floxuridine in patients with metastatic renal cell carcinoma, Cancer, 72, 2190, 10.1002/1097-0142(19931001)72:7<2190::AID-CNCR2820720721>3.0.CO;2-G Vokes, 1991, Five-day infusion of fluorodeoxyuridine with high-dose oral leucovorin: a phase I study, Cancer Chemother Pharmacol, 28, 69, 10.1007/BF00684960 Crider, 1986, Chemotherapy-induced acral erythema in patients receiving bone marrow transplantation, Arch Dermatol, 122, 1023, 10.1001/archderm.1986.01660210073021 Curran, 1989, Fluorouracil and palmar-plantar erythrodysesthesia, Ann Intern Med, 11, 858, 10.7326/0003-4819-111-10-858_1 De Argila, 1996, Taxol-induced acral erythema, Dermatology, 192, 377, 10.1159/000246419 Gordon, 1995, Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy, Cancer, 75, 2169, 10.1002/1097-0142(19950415)75:8<2169::AID-CNCR2820750822>3.0.CO;2-H Hellier, 1996, High-dose methotrexate-induced bullous variant of acral erythema, Arch Dermatol, 132, 590, 10.1001/archderm.1996.03890290132023 Kroll, 1989, Chemotherapy-induced acral erythema: desquamating lesions involving the hands and feet, Ann Plast Surg, 23, 263, 10.1097/00000637-198909000-00012 Lokich, 1984, Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome, Ann Intern Med, 101, 798, 10.7326/0003-4819-101-6-798 Muggia, 1997, Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation, J Clin Oncol, 15, 987, 10.1200/JCO.1997.15.3.987 Murphy, 1993, Dose-related cutaneous toxicities with etoposide, Cancer, 71, 3153, 10.1002/1097-0142(19930515)71:10<3153::AID-CNCR2820711042>3.0.CO;2-# Silver, 1983, Acral erythema and hydroxyurea, Ann Intern Med, 98, 611, 10.7326/0003-4819-98-5-675_2 Troussard, 1993, Acral erythema and acute GVHD, Bone Marrow Transplant, 11, 501 Waltzer, 1993, Bullous variant of chemotherapy-induced acral erythema, Arch Dermatol, 129, 43, 10.1001/archderm.1993.01680220055012 Zimmerman, 1995, Acute cutaneous reactions to docetaxel a new chemotherapeutic agent, Arch Dermatol, 131, 202, 10.1001/archderm.1995.01690140086015 Taal, 1993, Combination chemotherapy with tauromustine (TCNU), 5-fluorouracil and leucovorin in advanced colorectal carcinoma: a dose-finding study, Ann Oncol, 4, 81, 10.1093/oxfordjournals.annonc.a058369 Lowitt, 1995, Cutaneous eruptions from suramin: a clinical and histopathologic study of 60 patients, Arch Dermatol, 131, 1147, 10.1001/archderm.1995.01690220053010 Jucgla, 1997, Hand-foot syndrome, J Clin Oncol, 15, 3164, 10.1200/JCO.1997.15.9.3164 Oksenhendler, 1989, Acral erythema and systemic toxicity related to CHA induction therapy in acute myeloid leukemia, Eur J Cancer Clin Oncol, 25, 1181, 10.1016/0277-5379(89)90412-4 Schuster, 1989, Phase I-II trial of doxifluridine (5'DFUR) administered as long-term continuous infusion using a portable infusion pump for advanced colorectal cancer, Eur J Cancer Clin Oncol, 25, 1543, 10.1016/0277-5379(89)90295-2 Demircay, 1997, Chemotherapy-induced acral erythema in leukemic patients: a report of 15 cases, Int J Dermatol, 36, 593, 10.1046/j.1365-4362.1997.00040.x Burke, 1989, Chemotherapy-induced painful acral erythema in childhood: Burgdorf’s reaction, Am J Pediatr Hematol Oncol, 11, 44, 10.1097/00043426-198921000-00011 Horwitz, 1990, Acral erythema induced by chemotherapy and graft-versus-host disease in adults with hematogenous malignancies, Cutis, 46, 397 Walker, 1985, Cytarabine-induced palmar-plantar erythema, Arch Dermatol, 121, 1240, 10.1001/archderm.1985.01660100020006 Kampmann, 1989, Acral erythema secondary to high-dose cytosine arabinoside with pain worsened by cyclosporine infusions, Cancer, 63, 2482, 10.1002/1097-0142(19890615)63:12<2482::AID-CNCR2820631220>3.0.CO;2-E Vukelja, 1993, Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with taxotere, J Natl Cancer Inst, 85, 1432, 10.1093/jnci/85.17.1432 Vukelja, 1989, Pyridoxine for the palmar-plantar erythrodysesthesia syndrome, Ann Intern Med, 111, 688, 10.7326/0003-4819-111-8-688 Molina, 1987, Reversal of palmar-plantar erythrodysesthesia (PPE) by B6 without loss of response in colon cancer patients receiving 200 mg/m2/day continuous 5-FU, Proc Am Soc Clin Oncol, 6, 90 Fabian, 1990, Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion, Invest New Drugs, 8, 57, 10.1007/BF00216925 Brown, 1991, Treatment of cytarabine acral erythema with corticosteroids, J Am Acad Dermatol, 24, 1023, 10.1016/S0190-9622(08)80126-0 Jucgla, 1995, Palmoplantar keratoderma secondary to chronic acral erythema due to tegafur, Arch Dermatol, 131, 364, 10.1001/archderm.1995.01690150130035 Nemechek, 1992, Radiation recall associated with vinblastine in a patient treated for Kaposi sarcoma related to acquired immune deficiency syndrome, Cancer, 70, 1605, 10.1002/1097-0142(19920915)70:6<1605::AID-CNCR2820700627>3.0.CO;2-S Wallenborn, 1984, Radiation recall supraglottitis: a hazard in head and neck chemotherapy, Arch Otolaryngol, 110, 614, 10.1001/archotol.1984.00800350056015 Eifel, 1989, Severe chemotherapy-induced recall of radiation mucositis in a patient with non-Hodgkin’s lymphoma of Waldeyer’s ring, Int J Radiat Oncol Biol Phys, 17, 907, 10.1016/0360-3016(89)90086-2 DeSpain, 1992, Dermatologic toxicity of chemotherapy, Semin Oncol, 19, 501 Calvert, 1986, A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor N-10-propargyl-5,8-dideazafolic acid, CB3717, J Clin Oncol, 4, 1245, 10.1200/JCO.1986.4.8.1245 Williams, 1993, Ultraviolet recall associated with etoposide and cyclophosphamide therapy, Clin Exp Dermatol, 18, 452, 10.1111/j.1365-2230.1993.tb02249.x Andersen, 1984, Recall of UVB-induced erythema in breast cancer patient receiving multiple drug chemotherapy, Photodermatol, 1, 129 Kellie, 1987, Radiation recall and radiosensitization with alkylating agents, Lancet, 1, 1149, 10.1016/S0140-6736(87)91711-9 McCarty, 1996, Paclitaxel-induced radiation recall dermatitis, Med Pediatr Oncol, 27, 185, 10.1002/(SICI)1096-911X(199609)27:3<185::AID-MPO9>3.0.CO;2-A Raghavan, 1993, Taxol and radiation recall dermatitis, Lancet, 341, 1354, 10.1016/0140-6736(93)90871-D Schweitzer, 1995, Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel, Cancer, 76, 1069, 10.1002/1097-0142(19950915)76:6<1069::AID-CNCR2820760623>3.0.CO;2-7 Shenkier, 1994, Paclitaxel and radiation-recall dermatitis, J Clin Oncol, 12, 439, 10.1200/JCO.1994.12.2.439 Phillips, 1995, Radiation recall dermatitis in a patient treated with paclitaxel, J Clin Oncol, 13, 305, 10.1200/JCO.1995.13.1.305 Bokemeyer, 1996, Paclitaxel-induced radiation recall dermatitis, Ann Oncol, 7, 755, 10.1093/oxfordjournals.annonc.a010730 D’Angio, 1959, Potentiation of x-ray effects by actinomycin D, Radiology, 73, 175, 10.1148/73.2.175 Yeo, 1996, Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold, Eur J Cancer, 33, 698, 10.1016/S0959-8049(96)00461-3 Parry, 1992, Radiation recall dermatitis induced by tamoxifen, Lancet, 340, 49, 10.1016/0140-6736(92)92460-W Exterman, 1995, Radiation recall in a patient with breast cancer treated for tuberculosis, Eur J Clin Pharmacol, 48, 77, 10.1007/BF00202177 Gabel, 1995, Radiation recall reaction to idarubicin resulting in vaginal necrosis, Gynecol Oncol, 57, 266, 10.1006/gyno.1995.1139 Pui, 1988, Phase I clinical trial of orally administered 4-demethoxydaunorubicin (idarubicin) with pharmacokinetic and in vitro drug sensitivity testing in children with refractory leukemia, Cancer Res, 48, 5348 Perez, 1995, Radiation recall dermatitis induced by edatrexate in a patient with breast cancer, Cancer Invest, 13, 604, 10.3109/07357909509024929 Stelzer, 1993, Radiation recall skin toxicity with bleomycin in a patient with Kaposi sarcoma related to acquired immune deficiency syndrome, Cancer, 71, 1322, 10.1002/1097-0142(19930215)71:4<1322::AID-CNCR2820710425>3.0.CO;2-Z Burdon, 1978, Adriamycin-induced recall phenomenon 15 years after radiotherapy, JAMA, 239, 931, 10.1001/jama.1978.03280370027018 Phillips, 1976, Quantification of combined radiation therapy and chemotherapy effects on critical normal tissues, Cancer, 37, 1186, 10.1002/1097-0142(197602)37:2+<1186::AID-CNCR2820370830>3.0.CO;2-V Van Houtte, 1994, Toxicity of combined radiation and chemotherapy in non-small cell lung cancer, Lung Cancer, 10, S271, 10.1016/0169-5002(94)91691-8 O’Rourke, 1987, Enhanced cutaneous effects in combined modality therapy, Oncol Nurs Forum, 14, 31 Aristizabal, 1979, Combined radiation-Adriamycin effects on human skin, Front Radiat Ther Oncol, 13, 103, 10.1159/000402482 Geara, 1991, Radiotherapy in the management of cutaneous epidemic Kaposi’s sarcoma, Int J Radiat Oncol Biol Phys, 21, 1517, 10.1016/0360-3016(91)90327-Z Allen, 1993, Drug-induced photosensitivity, Clin Pharmacy, 12, 580 Horio, 1978, Photosensitivity due to a fluorouracil derivative, Arch Dermatol, 114, 1498, 10.1001/archderm.1978.01640220047012 Usuki, 1997, Tegafur-induced photosensitivity: evaluation of provocation by UVB irradiation, Int J Dermatol, 36, 604 Anonymous, 1995, Drugs that cause photosensitivity, Med Lett Drugs Ther, 37, 35 Korossy, 1981, Methotrexate reactivation of sunburn reaction, Arch Dermatol, 117, 310, 10.1001/archderm.1981.01650050066027 Schwartsmann, 1989, Mucocutaneous side effects of brequinar sodium: a new inhibitor of pyrimidine de novo biosynthesis, Cancer, 63, 243, 10.1002/1097-0142(19890115)63:2<243::AID-CNCR2820630207>3.0.CO;2-7 Potter, 1994, Cutaneous photosensitivity to medications, Compr Ther, 20, 414 Zimm, 1988, Phase I/pharmokinetic study of thioguanine administered as a 48-hour continuous intraperitoneal infusion, J Clin Oncol, 6, 696, 10.1200/JCO.1988.6.4.696 Gould, 1995, Cutaneous photosensitivity diseases induced by exogenous agents, J Am Acad Dermatol, 33, 551, 10.1016/0190-9622(95)91271-1 Fujimoto, 1996, Photosensitive dermatitis induced by flutamide, Br J Dermatol, 135, 496, 10.1111/j.1365-2133.1996.tb01532.x Leroy, 1996, Flutamide photosensitivity, Photodermatol Photoimmunol Photomed, 12, 216, 10.1111/j.1600-0781.1996.tb00203.x Moraillon, 1991, Photoallergic reaction induced by flutamide, Photodermatol Photoimmunol Photomed, 8, 264 Dougherty, 1990, Cutaneous phototoxic occurrences in patients receiving Photofrin, Lasers Surg Med, 10, 485, 10.1002/lsm.1900100514 Wooten, 1988, Prospective study of cutaneous phototoxicity after systemic hematoporphyrin derivative, Lasers Surg Med, 8, 294, 10.1002/lsm.1900080312 Horio, 1986, Tegaful photosensitivity: lichenoid and eczematous types, Photodermatology, 3, 192 Mallory, 1986, Severe reactivation of sunburn following methotrexate use, Pediatrics, 78, 514, 10.1542/peds.78.3.514 Falkson, 1962, Skin changes in patients treated with 5-flourouracil, Br J Dermatol, 74, 229, 10.1111/j.1365-2133.1962.tb13497.x Omura, 1969, Inflammation of actinic keratoses due to systemic fluorouracil therapy, JAMA, 208, 150, 10.1001/jama.1969.03160010146027 Camisa, 1985, Deoxycoformycin: a new chemotherapeutic agent of interest to dermatologists, J Am Acad Dermatol, 12, 1108, 10.1016/S0190-9622(85)80201-2 Hardwick, 1986, Inflammation of actinic keratoses induced by cytotoxic drugs, Br J Dermatol, 114, 639, 10.1111/j.1365-2133.1986.tb04078.x Johnson, 1987, Inflammation of actinic keratoses from systemic chemotherapy, J Am Acad Dermatol, 17, 192, 10.1016/S0190-9622(87)70189-3 Sollitto, 1994, An oncology patient with an erythematous papulosquamous eruption in sun-exposed areas: inflamed actinic keratoses due to systemic chemotherapy, Arch Dermatol, 130, 1194, 10.1001/archderm.130.9.1194 Bataille, 1996, Inflammation of solar keratoses following systemic 5-fluorouracil, Br J Dermatol, 135, 478, 10.1111/j.1365-2133.1996.tb01520.x Kechijian, 1979, Cytarabine-induced inflammation in the seborrheic keratoses of Leser-Trelat, Ann Intern Med, 91, 868, 10.7326/0003-4819-91-6-868 Davidovitz, 1997, Flare-up of squamous cell carcinoma of the skin following fludarabine therapy for chronic lymphocytic leukemia, Acta Haematol, 98, 44, 10.1159/000203561 Weiss, 1987, Hypersensitivity reactions from antineoplastic agents, Cancer Metastasis Rev, 6, 413, 10.1007/BF00144273 Weiss, 1992, Hypersensitivity reactions, Semin Oncol, 19, 458 Wilkin, 1993, The red face: flushing disorders, Clin Dermatol, 11, 211, 10.1016/0738-081X(93)90057-J Wilkin, 1992, Flushing reactions in the cancer chemotherapy patient: the lists are longer but the strategies are the same, Arch Dermatol, 128, 1387, 10.1001/archderm.1992.01680200097016 Prussick, 1996, Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy, Semin Cutan Med Surg, 15, 267, 10.1016/S1085-5629(96)80040-X Woo, 1997, Headache, circumoral paresthesia, and facial flushing associated with high-dose carmustine infusion, Bone Marrow Transplant, 19, 845, 10.1038/sj.bmt.1700743 Henner, 1986, Pharmacokinetics and immediate effects of high-dose carmustine in man, Cancer Treat Rep, 70, 877 Spiegel, 1981, The acute toxicities of chemotherapy, Cancer Treat Rev, 8, 197, 10.1016/S0305-7372(81)80017-5 Weidmann, 1994, Hypersensitivity reactions to carboplatin: report of two patients, review of the literature, and discussion of diagnostic procedures and management, Cancer, 73, 2218, 10.1002/1097-0142(19940415)73:8<2218::AID-CNCR2820730830>3.0.CO;2-1 Chang, 1995, Carboplatin hypersensitivity in children: a report of five patients with brain tumors, Cancer, 75, 1171, 10.1002/1097-0142(19950301)75:5<1171::AID-CNCR2820750518>3.0.CO;2-F Dhar, 1994, Facial flushing: a side effect of pulse therapy, Dermatology, 188, 332, 10.1159/000247180 Sondak, 1994, Didemnin B in metastatic malignant melanoma: a phase II trial of the Southwest Oncology Group, Anticancer Drugs, 5, 147, 10.1097/00001813-199404000-00004 Westermann, 1996, Successful docetaxel rechallenge with cromoglycate after major sensitivity reactions, Ann Oncol, 7, 104, 10.1093/oxfordjournals.annonc.a010459 Trudeau, 1996, Docetaxel: a review of its pharmacology and clinical activity, Can J Oncol, 6, 443 Curran, 1992, Doxorubicin associated facial flushing, Arch Dermatol, 128, 1408, 10.1001/archderm.1992.01680200120029 Breathnach, 1992, Adverse drug reactions and the skin, 394 Sternberg, 1985, Phase II trial of elliptinium in advanced renal cell carcinoma and carcinoma of the breast, Anticancer Res, 5, 415 De Souza, 1994, Hypersensitivity reactions to etoposide: a report of three cases and review of the literature, Am J Clin Oncol, 17, 387, 10.1097/00000421-199410000-00005 Ives, 1995, Patient experiences adverse drug reaction to etoposide for adenocarcinoma of the lung, Oncol Nurs Forum, 22, 1289 Ogle, 1988, Hypersensitivity reactions to etoposide: a case report and review of the literature, Am J Clin Oncol, 11, 663, 10.1097/00000421-198812000-00015 Fellner, 1993, The red face: drugs, chemicals and other causes, Clin Dermatol, 11, 315, 10.1016/0738-081X(93)90068-N Gallagher, 1995, Management of cutaneous symptoms, Semin Oncol Nurs, 11, 239, 10.1016/S0749-2081(05)80004-X Kennedy, 1970, Metabolic and toxic effects of mithramycin during tumor therapy, Am J Med, 49, 494, 10.1016/S0002-9343(70)80044-4 Spivack, 1974, Drugs 5 years later: procarbazine, Ann Intern Med, 81, 795, 10.7326/0003-4819-81-6-795 Nolte, 1988, VM-26 (teniposide)– induced hypersensitivity and degranulation of basophils in children, Am J Pediatr Hematol Oncol, 10, 308, 10.1097/00043426-198824000-00007 Grem, 1990, Hypersensitivity reactions to trimetrexate, Invest New Drugs, 8, 211, 10.1007/BF00177263 Ingle, 1981, Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer, N Engl J Med, 304, 16, 10.1056/NEJM198101013040104 Harrist, 1982, Neutrophilic eccrine hidradenitis: a distinctive type of neutrophilic dermatosis associated with myelogenous leukemia and chemotherapy, Arch Dermatol, 118, 263, 10.1001/archderm.1982.01650160053024 Flynn, 1984, Neutrophilic eccrine hidradenitis: a distinctive rash associated with cytarabine therapy and acute leukemia, J Am Acad Dermatol, 4, 584, 10.1016/S0190-9622(84)70210-6 Beutner, 1986, Neutrophilic eccrine hidradenitis associated with Hodgkin’s disease and chemotherapy, Arch Dermatol, 122, 809, 10.1001/archderm.1986.01660190087022 Scallan, 1988, Neutrophilic eccrine hidradenitis: evidence implicating bleomycin as a causative agent, Cancer, 62, 2532, 10.1002/1097-0142(19881215)62:12<2532::AID-CNCR2820621214>3.0.CO;2-D Katansis, 1987, Neutrophilic eccrine hidradenitis in acute myelomonocytic leukemia, Am J Pediatr Hematol Oncol, 9, 204 Bailey, 1989, Neutrophilic eccrine hidradenitis: a case report and review of the literature, Pediatr Dermatol, 6, 33, 10.1111/j.1525-1470.1989.tb00264.x Greenbaum, 1988, Chemotherapy-associated eccrine hidradenitis: neutrophilic eccrine hidradenitis reevaluated: the role of neutrophilic infiltration, Med Pediatr Oncol, 16, 351, 10.1002/mpo.2950160513 Allegue, 1990, Neutrophilic eccrine hidradenitis in two neutropenic patients, J Am Acad Dermatol, 23, 1110, 10.1016/0190-9622(90)70342-F Cogolludo, 1989, Neutrophilic eccrine hidradenitis: a report of two additional cases, Clin Exp Dermatol, 14, 341, 10.1111/j.1365-2230.1989.tb02580.x Vion, 1991, Neutrophilic eccrine hidradenitis, Dermatologica, 183, 70, 10.1159/000247641 Scherbenske, 1990, Asymptomatic erythematous papules in a leukemic patient: neutrophilic eccrine hidradenitis, Arch Dermatol, 126, 528, 10.1001/archderm.126.4.528 Thorisdottir, 1993, Neutrophilic eccrine hidradenitis, J Am Acad Dermatol, 28, 775, 10.1016/0190-9622(93)70090-G Templeton, 1994, Intradermal bleomycin injections into normal human skin: a histopathologic and immunopathologic study, Arch Dermatol, 130, 577, 10.1001/archderm.1994.01690050045006 Hurt, 1990, Eccrine squamous syringometaplasia, A cutaneous sweat gland reaction in the histologic spectrum of ‘chemotherapy-associated eccrine hidradenitis’ and ‘neutrophilic eccrine hidradenitis.’ Arch Dermatol, 126, 73 Shear, 1996, Dapsone prevention of recurrent neutrophilic eccrine hidradenitis, J Am Acad Dermatol, 35, 819, 10.1016/S0190-9622(96)90092-4 Bernstein, 1992, Recurrent neutrophilic eccrine hidradenitis, Br J Dermatol, 127, 529, 10.1111/j.1365-2133.1992.tb14854.x Margolis, 1991, Neutrophilic eccrine hidradenitis: a case report and review of the literature, Cutis, 48, 198 Scong, 1991, Annular plaques on the dorsa of the hands: neutrophilic eccrine hidradenitis, Arch Dermatol, 127, 1398, 10.1001/archderm.127.9.1398 Bardenstein, 1994, Neutrophilic eccrine hidradenitis simulating orbital cellulitis, Arch Ophthalmol, 112, 1460, 10.1001/archopht.1994.01090230074023 Kuttner, 1988, Neutrophilic eccrine hidradenitis in the absence of an underlying malignancy, Cutis, 41, 403 Moreno, 1985, Infectious eccrine hidradenitis in a patient undergoing hemodialysis, Arch Dermatol, 121, 1106, 10.1001/archderm.1985.01660090020005 Smith, 1990, Neutrophilic eccrine hidradenitis in HIV-infected patients, J Am Acad Dermatol, 23, 945, 10.1016/S0190-9622(08)80707-4 Allegue, 1990, Infectious eccrine hidradenitis, J Am Acad Dermatol, 22, 1119, 10.1016/S0190-9622(08)81022-5 Pierson, 1993, Neutrophilic eccrine hidradenitis heralding the onset of acute myelogenous leukemia, Arch Dermatol, 129, 791, 10.1001/archderm.1993.01680270135026 Osterle, 1993, Neutrophilic eccrine hidradenitis with an unusual presentation, Br J Dermatol, 128, 696, 10.1111/j.1365-2133.1993.tb00269.x Aractingi, 1995, Neutrophilic dermatoses during granulocytopenia, Arch Dermatol, 131, 1141, 10.1001/archderm.1995.01690220047009 Brehler, 1997, Neutrophilic hidradenitis induced by chemotherapy involves eccrine and apocrine glands, Am J Dermatopathol, 19, 73, 10.1097/00000372-199702000-00013 Horn, 1989, Observations and proposed mechanism of N,N'N''-triethylenethiophosphoramide (thiotepa)-induced hyperpigmentation, Arch Dermatol, 125, 524, 10.1001/archderm.1989.01670160072011 Madsen, 1988, Excretion of mutagens in sweat from humans treated with antineoplastic agents, Cancer Lett, 40, 199, 10.1016/0304-3835(88)90011-0 Hu, 1991, Sweat-related dermatoses: old concepts and new scenario, Dermatologica, 182, 73, 10.1159/000247748 Nikkels, 1993, Neutrophilic eccrine hidradenitis: a case report, Acta Clin Belg, 48, 397, 10.1080/17843286.1993.11718336 Munoz, 1997, Herpetic syringitis associated with eccrine squamous syringometaplasia in HIV positive patients, J Cutan Pathol, 24, 425, 10.1111/j.1600-0560.1997.tb00817.x Valks, 1996, Eccrine squamous syringometaplasia in intertriginous areas, Br J Dermatol, 134, 984, 10.1111/j.1365-2133.1996.tb06347.x Valks, 1997, Chemotherapy-induced eccrine squamous syringometaplasia, Arch Dermatol, 133, 873, 10.1001/archderm.1997.03890430089012 Bhawan, 1990, Syringosquamous metaplasia: a distinctive eruption in patients receiving chemotherapy, Am J Dermatopathol, 12, 1, 10.1097/00000372-199002000-00001 Rongioletti, 1991, Necrotizing eccrine squamous syringometaplasia presenting as acral erythema, J Cutan Pathol, 18, 453, 10.1111/j.1600-0560.1991.tb01384.x Rios-Buceta, 1995, Recall phenomenon with the unusual presence of eccrine squamous syringometaplasia, Br J Dermatol, 133, 630, 10.1111/j.1365-2133.1995.tb02718.x Wong, 1993, A papulovesicular eruption in a man receiving chemotherapy for metastatic melanoma, Arch Dermatol, 129, 232, 10.1001/archderm.129.2.232 Horn, 1989, Cutaneous eruptions of lymphocyte recovery, Arch Dermatol, 125, 1512, 10.1001/archderm.1989.01670230054008 Horn, 1996, Systemic cytokine administration alters the histology of the eruption of lymphocyte recovery, J Cutan Pathol, 23, 242, 10.1111/j.1600-0560.1996.tb01473.x Horn, 1994, Acute cutaneous eruptions after marrow ablation: Roses by other names?, J Cutan Pathol, 21, 385, 10.1111/j.1600-0560.1994.tb00277.x Fitzpatrick, 1992, New histopathologic findings in drug eruptions, Dermatol Clin, 10, 19, 10.1016/S0733-8635(18)30352-8 Bauer, 1993, Histologic comparison of autologous graft-vs-host reaction and cutaneous eruption of lymphocyte recovery, Arch Dermatol, 129, 855, 10.1001/archderm.1993.01680280043007 Vonderheid, 1984, Topical mechlorethamine chemotherapy: considerations on its use in mycosis fungoides, Int J Dermatol, 23, 180, 10.1111/j.1365-4362.1984.tb04507.x Van Scott, 1970, Responses of mycosis fungoides to intensive external treatment with nitrogen mustard, Arch Dermatol, 102, 507, 10.1001/archderm.1970.04000110023004 Mandy, 1971, Topically applied mechlorethamine in the treatment of psoriasis, Arch Dermatol, 103, 272, 10.1001/archderm.1971.04000150042006 Flaxman, 1973, Changes in melanosome distribution in caucasoid skin following topical application of nitrogen mustard, J Invest Dermatol, 60, 321, 10.1111/1523-1747.ep12723167 Epstein, 1970, Effects of topical mechlorethamine on skin lesions of psoriasis, Arch Dermatol, 102, 504, 10.1001/archderm.1970.04000110020003 Manzione, 1988, Development of porphyria cutanea tarda after treatment with cyclophosphamide, Gastroenterology, 95, 1119, 10.1016/0016-5085(88)90191-6 Romankiewicz, 1974, Cyclophosphamide and pigmentation, Am J Hosp Pharm, 31, 1074 Bublin, 1992, Drug-induced hair colour changes, J Clin Pharmacol Ther, 17, 297, 10.1111/j.1365-2710.1992.tb01307.x Yule, 1994, Ifosfamide-induced hyperpigmentation, Cancer, 73, 240, 10.1002/1097-0142(19940101)73:1<240::AID-CNCR2820730141>3.0.CO;2-6 Teresi, 1993, Ifosfamide-induced hyperpigmentation, Cancer, 71, 2873, 10.1002/1097-0142(19930501)71:9<2873::AID-CNCR2820710931>3.0.CO;2-6 Frost, 1966, Pigmentation due to a new antitumor agent, Arch Dermatol, 94, 265, 10.1001/archderm.1966.01600270015003 Claudy, 1992, Serpentine supravenous hyperpigmentation induced by the nitrosourea fotemustine, Dermatology, 184, 70, 10.1159/000247504 Al-Lamki, 1996, Localized cisplatin hyperpigmentation induced by pressure: a case report, Cancer, 77, 1578, 10.1002/(SICI)1097-0142(19960415)77:8<1578::AID-CNCR23>3.0.CO;2-W Harben, 1979, Thiotepa-induced leukoderma, Arch Dermatol, 115, 973, 10.1001/archderm.1979.04010080037019 Vukelja, 1991, Unusual serpentine hyperpigmentation associated with 5-fluorouracil: case report and review of cutaneous manifestations associated with systemic 5-fluorouracil, J Am Acad Dermatol, 25, 905, 10.1016/0190-9622(91)70280-F Hrushesky, 1976, Serpentine supravenous 5-fluorouracil (NSC-19893) hyperpigmentation, Cancer Treat Rep, 60, 639 Hrushesky, 1980, Unusual pigmentary changes associated with 5-fluorouracil therapy, Cutis, 26, 181 Allen, 1995, Reticulate pigmentation due to 5-fluorouracil, Int J Dermatol, 34, 219, 10.1111/j.1365-4362.1995.tb01579.x Pearlman, 1987, Weekly psoriasis therapy using intralesional fluorouracil, J Am Acad Dermatol, 17, 78, 10.1016/S0190-9622(87)70175-3 Llistosella, 1991, Tegafur-induced acral hyperpigmentation, Cutis, 48, 205 Wada, 1995, Combined chemoendocrine treatment with tegafur and tamoxifen for advanced renal cell carcinoma, Anticancer Res, 15, 1581 Wheeland, 1983, The flag sign of chemotherapy, Cancer, 51, 1356, 10.1002/1097-0142(19830415)51:8<1356::AID-CNCR2820510806>3.0.CO;2-6 Cohen, 1973, Cutaneous toxicity of bleomycin therapy, Arch Dermatol, 107, 553, 10.1001/archderm.1973.01620190029007 Lazar, 1988, Streaky pigmentation in a patient with acquired immune deficiency syndrome (AIDS), Cutis, 42, 397 Watanabe, 1995, ‘Flagellate’ erythema in dermatomyositis, Dermatology, 190, 230, 10.1159/000246691 Guillet, 1986, Cutaneous pigmented stripes and bleomycin treatment, Arch Dermatol, 122, 381, 10.1001/archderm.1986.01660160031013 Fernandez-Obregon, 1985, Flagellate pigmentation from intrapleural bleomycin: a light microscopy and electron microscopy study, J Am Acad Dermatol, 13, 464, 10.1016/S0190-9622(85)70190-9 Tsuji, 1993, Hyperpigmentation in striae distensae after bleomycin treatment, J Am Acad Dermatol, 28, 503, 10.1016/S0190-9622(08)81768-9 Hendrix, 1992, Cutaneous hyperpigmentation caused by systemic drugs, Int J Dermatol, 31, 458, 10.1111/j.1365-4362.1992.tb02689.x Kanwar, 1995, Unusual cutaneous toxicity following treatment with dactinomycin: a report of two cases, Med Pediatr Oncol, 24, 329, 10.1002/mpo.2950240512 Kelly, 1984, Hyperpigmentation with daunorubicin therapy, Arch Dermatol, 120, 262, 10.1001/archderm.1984.01650380122026 Anderson, 1992, Cutaneous pigmentation after daunorubicin chemotherapy, J Am Acad Dermatol, 26, 255, 10.1016/S0190-9622(08)80301-5 Kew, 1977, Melanocyte stimulating-hormone levels in doxorubicin-induced hyperpigmentation, Lancet, 1, 811, 10.1016/S0140-6736(77)93006-9 Kumar, 1990, Doxorubicin induced hyperpigmentation, N Z Med J, 103, 165 Curran, 1990, Doxorubicin-associated hyperpigmentation, N Z Med J, 103, 517 Konohana, 1992, Blue-gray pigmentation in a patient receiving doxorubicin, J Dermatol, 19, 250, 10.1111/j.1346-8138.1992.tb03218.x Kumar, 1990, Mitoxantrone induced hyperpigmentation, N Z Medical J, 103, 55 Gropper, 1993, Nail and skin hyperpigmentation associated with hydroxyurea therapy for polycythemia vera, Int J Dermatol, 32, 731, 10.1111/j.1365-4362.1993.tb02745.x Cecchi, 1994, Supravenous hyperpigmentation induced by vinorelbine, Dermatology, 188, 244, 10.1159/000247152 Singal, 1991, Discrete pigmentation after chemotherapy, Pediatr Dermatol, 8, 231, 10.1111/j.1525-1470.1991.tb00867.x Prussick, 1996, A characteristic eruption associated with ifosfamide, carboplatin, and etoposide chemotherapy after pretreatment with recombinant interleukin-1, J Am Acad Dermatol, 35, 705, 10.1016/S0190-9622(96)90725-2 Loureiro, 1987, Red hair and hyperpigmentation in a black man after chemotherapy, J Clin Oncol, 5, 1705, 10.1200/JCO.1987.5.10.1705 Schulte-Huermann, 1995, Supravenous hyperpigmentation in association with CHOP chemotherapy of a CD30 (Ki-1)-positive anaplastic large-cell lymphoma, Dermatology, 191, 65, 10.1159/000246493 Baselga, 1996, Chemotherapy-associated supravenous hyperpigmentation, Dermatology, 192, 384, 10.1159/000246423 Morgan, 1991, The toxicity of busulphan and cyclophosphamide as the preparative regimen for bone marrow transplantation, Br J Haematol, 77, 529, 10.1111/j.1365-2141.1991.tb08621.x Bandini, 1994, Toxicity of high-dose busulphan and cyclophosphamide as conditioning therapy for allogeneic bone marrow transplantation in adults with haematological malignancies, Bone Marrow Transplant, 13, 577 Litt, 1998, Drug eruption reference manual, 564 Daniel, 1982, Nail pigmentation abnormalities: their importance and proper examination, Cutis, 30, 348 Cakir, 1997, Longitudinal pigmented nail bands during hydroxyurea therapy, Int J Dermatol, 36, 234 Shah, 1978, Cyclophosphamide induced nail pigmentation, Br J Dermatol, 98, 675, 10.1111/j.1365-2133.1978.tb03587.x Daniel, 1984, Nail changes secondary to systemic drugs or ingestants, J Am Acad Dermatol, 10, 250, 10.1016/S0190-9622(84)70032-6 Shelley, 1997, Transverse leukonychia (Mees’ lines) due to daunorubicin chemotherapy, Pediatr Dermatol, 14, 144, 10.1111/j.1525-1470.1997.tb00222.x Wong, 1984, Oral etoposide and gestational trophoblastic disease, Cancer Treat Rep, 68, 775 Kwong, 1996, Hydroxyurea-induced nail pigmentation, J Am Acad Dermatol, 35, 275, 10.1016/S0190-9622(96)90353-9 Borecky, 1997, Idarubicin-induced pigmentary changes of the nails, Cutis, 59, 203 Shetty, 1977, Case of pigmented banding of the nail caused by bleomycin, Cancer Treat Rep, 61, 501 Victoroff, 1993, Transverse white lines in the fingernails induced by combination chemotherapy, Arch Dermatol, 129, 1217, 10.1001/archderm.1993.01680300147036 Kowal-Vern, 1993, Unusual erythema of the proximal nail fold and onychodermal band, Cutis, 52, 43 Unamuno, 1992, Leukonychia due to cytostatic agents, Clin Exp Dermatol, 17, 273, 10.1111/j.1365-2230.1992.tb02166.x Perlin, 1991, Pigmentary effects from the protracted infusion of 5-fluorouracil, Int J Dermatol, 30, 43, 10.1111/j.1365-4362.1991.tb05878.x Harrison, 1972, Cyclophosphamide and pigmentation, Br Med J, 1, 352, 10.1136/bmj.2.5809.352-b Alkins, 1996, Anaphylactoid reactions to methotrexate, Cancer, 77, 2123, 10.1002/(SICI)1097-0142(19960515)77:10<2123::AID-CNCR24>3.0.CO;2-W Broome, 1996, Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions, Med Pediatr Oncol, 26, 105, 10.1002/(SICI)1096-911X(199602)26:2<105::AID-MPO7>3.0.CO;2-P Posada, 1984, Anaphylactic reactions to diaziquone, Cancer Treat Rep, 68, 1215 Schrijvers, 1993, Coping with toxicities of docetaxel (Taxotere), Ann Oncol, 4, 610, 10.1093/oxfordjournals.annonc.a058599 Crawford, 1986, Adverse reactions to the intravesical administration of doxorubicin hydrochloride: report of 6 cases, J Urol, 136, 668, 10.1016/S0022-5347(17)45010-5 Lee, 1987, Generalized hypersensitivity reaction to intravesical thiotepa and doxorubicin, J Urol, 138, 143, 10.1016/S0022-5347(17)43025-4 Cassidy, 1989, Hypersensitivity reaction to epirubicin, Med Oncol Tumor Pharmacother, 6, 297, 10.1007/BF02985165 Geggie, 1987, Methotrexate allergy, Can Med Assoc J, 137, 103 Veenema, 1969, Thiotepa bladder instillations: therapy and prophylaxis for superficial bladder tumors, J Urol, 101, 711, 10.1016/S0022-5347(17)62408-X Greenspan, 1977, Thiotepa, cutaneous reactions, and efficacy, JAMA, 237, 2288, 10.1001/jama.1977.03270480028009 Gregory, 1993, Paclitaxel: a new antineoplastic agent for refractory ovarian cancer, Clin Pharm, 12, 401 Weiss, 1990, Hypersensitivity reactions from taxol, J Clin Oncol, 8, 1263, 10.1200/JCO.1990.8.7.1263 Tonkin, 1993, Carboplatin hypersensitivity: case reports and review of the literature, Eur J Cancer, 29A, 1356, 10.1016/0959-8049(93)90093-U Taylor, 1986, Allergic reactions to mitoxantrone, Lancet, 1, 1439, 10.1016/S0140-6736(86)91580-1 Craig, 1985, The prevention and treatment of immediate hypersensitivity reactions from cancer chemotherapy, Semin Oncol Nurs, 1, 285, 10.1016/0749-2081(85)90009-9 Spencer, 1984, Local erythema multiforme-like drug reaction following intravenous mitomycin C and 5-fluorouracil, J Surg Oncol, 26, 47, 10.1002/jso.2930260111 O’Brien, 1992, Allergic reactions to cytotoxic drugs: an update, Ann Oncol, 3, 605, 10.1093/oxfordjournals.annonc.a058285 Lee, 1984, Morbilliform skin eruption owing to diethylstilbestrol, J Urol, 131, 767, 10.1016/S0022-5347(17)50615-1 Gassel, 1984, Acute allergic reaction due to vincristine sulfate, Oncology, 41, 403, 10.1159/000225864 Newman, 1997, Stevens-Johnson syndrome associated with topical nitrogen mustard therapy, J Am Acad Dermatol, 36, 112, 10.1016/S0190-9622(97)70341-4 Katz, 1995, Erythema multiforme induced by suramin, J Am Acad Dermatol, 32, 292, 10.1016/0190-9622(95)90154-X Taylor, 1989, Methotrexate-induced erythema multiforme, Gynecol Oncol, 33, 376, 10.1016/0090-8258(89)90531-3 Brodsky, 1989, Stevens-Johnson syndrome, respiratory distress and acute renal failure due to synergic bleomycin cisplatin toxicity, J Clin Pharmacol, 29, 821, 10.1002/j.1552-4604.1989.tb03426.x Giaccone, 1986, Stevens-Johnson syndrome and fatal pulmonary toxicity to combination chemotherapy containing bleomycin: a case report, Tumori, 72, 331, 10.1177/030089168607200316 Leititis, 1985, Stevens-Johnson syndrome during an immunosuppressive therapy with cyclophosphamide and prednisone, Klin Padiatr, 197, 441, 10.1055/s-2008-1034018 Assier-Bonnet, 1996, Stevens-Johnson syndrome induced by cyclophosphamide: report of two cases, Br J Dermatol, 135, 864, 10.1111/j.1365-2133.1996.tb03915.x Payne, 1996, Paclitaxel: severe mucocutaneous toxicity in a patient with hyperbilirubinemia, South Med J, 89, 542, 10.1097/00007611-199605000-00022 Hitchins, 1987, Chlorambucil allergy: a series of three cases, Aust N Z J Med, 17, 600, 10.1111/j.1445-5994.1987.tb01268.x Rodriguez, 1980, Asparaginase and toxic epidermal necrolysis, J Med Assoc Ga, 69, 355 Stern, 1989, Usefulness of case report literature in determining drugs responsible for toxic epidermal necrolysis, J Am Acad Dermatol, 21, 317, 10.1016/S0190-9622(89)70176-6 Primka, 1997, Methotrexate-induced toxic epidermal necrolysis in a patient with psoriasis, J Am Acad Dermatol, 36, 815, 10.1016/S0190-9622(97)70029-X Reed, 1983, Methotrexate-induced necrolysis, J Am Acad Dermatol, 8, 677, 10.1016/S0190-9622(83)70079-4 Pietrantonio, 1990, Unusual reaction to chlorambucil: a case report, Cancer Lett, 54, 109, 10.1016/0304-3835(90)90030-2 Barone, 1990, Toxic epidermal necrolysis during chlorambucil therapy in chronic lymphocytic leukemia, Eur J Cancer, 26, 1262, 10.1016/0277-5379(90)90283-Y Aydogdu, 1997, Severe adverse skin reaction to chlorambucil in a patient with chronic lymphocytic leukemia, Anticancer Drugs, 8, 468, 10.1097/00001813-199706000-00009 Meunier, 1996, Cutaneous reactions after treatment with 2-chlorodeoxyadenosine, Acta Derm Venereol (Stockh), 76, 385 May, 1991, Fatal toxic epidermal necrolysis during suramin therapy, Eur J Cancer, 27, 1338, 10.1016/0277-5379(91)90118-W Rapoport, 1991, A phase II clinical study of suramin in combination with mitomycin C in patients with non small cell lung cancer, Lung Cancer, 7, 323, 10.1016/0169-5002(91)90029-6 Andersen, 1997, Serum sickness associated with 6-mercaptopurine in a patient with Crohn’s disease, Pharmacotherapy, 17, 173 Jain, 1993, Drug-induced cutaneous vasculitis, Adverse Drug Reac Toxicol, 12, 263 Green, 1989, Cutaneous vasculitis due to cyclophosphamide therapy for chronic lymphocytic leukemia, Aust N Z J Med, 19, 55, 10.1111/j.1445-5994.1989.tb01677.x Giordano, 1996, Atypical methotrexate dermatitis in a patient with rheumatoid arthritis, Clin Exp Rheumatol, 14, 450 Drago, 1990, Tamoxifen and purpuric vasculitis, Ann Intern Med, 112, 965, 10.7326/0003-4819-112-12-965_2 Schena, 1996, Occupational contact urticaria due to cisplatin, Contact Dermatitis, 34, 220, 10.1111/j.1600-0536.1996.tb02181.x Nadal, 1996, Systemic contact dermatitis from 5-fluorouracil, Contact Dermatitis, 35, 124, 10.1111/j.1600-0536.1996.tb02320.x Goette, 1982, Treatment of keratoacanthoma with topical application of fluorouracil, Arch Dermatol, 118, 309, 10.1001/archderm.1982.01650170023015 Tennstedt, 1987, Allergic contact dermatitis to 5-fluorouracil, Contact Dermatitis, 16, 279, 10.1111/j.1600-0536.1987.tb01456.x Sevadjian, 1985, Pustular contact hypersensitivity to fluorouracil with rosacealike sequelae, Arch Dermatol, 121, 240, 10.1001/archderm.1985.01660020098027 Goette, 1981, Topical chemotherapy with 5-fluorouracil, J Am Acad Dermatol, 4, 633, 10.1016/S0190-9622(81)80196-X Echechipia, 1995, Generalized dermatitis due to mitomycin C patch test, Contact Dermatitis, 33, 432, 10.1111/j.1600-0536.1995.tb02084.x Vidal, 1992, Three cases of allergic dermatitis due to intravesical mitomycin C, Dermatology, 184, 208, 10.1159/000247543 Gomez Torrijos, 1997, Allergic contact dermatitis from mitomycin C, Allergy, 52, 687, 10.1111/j.1398-9995.1997.tb01061.x Fisher, 1991, Allergic contact dermatitis to mitomycin-C, Cutis, 47, 225 Giorgini, 1991, Delayed-type sensitivity reaction to mitomycin, Contact Dermatitis, 24, 378, 10.1111/j.1600-0536.1991.tb01761.x Arregui, 1991, Dermatitis due to mitomycin C bladder instillations: study of 2 cases, Contact Dermatitis, 24, 368, 10.1111/j.1600-0536.1991.tb01754.x de Groot, 1991, Systemic allergic contact dermatitis from intravesical instillation of the antitumor antibiotic mitomycin C, Contact Dermatitis, 24, 201, 10.1111/j.1600-0536.1991.tb01699.x Colver, 1990, Dermatitis due to intravesical mitomycin C: A delayed-type hypersensitivity reaction?, Br J Dermatol, 122, 217, 10.1111/j.1365-2133.1990.tb08268.x Hoetelmans, 1996, Hypersensitivity reactions to etoposide, Ann Pharmacother, 30, 367, 10.1177/106002809603000409 Bernstein, 1977, Skin reactions to 5-fluorouracil, NeEngl J Med, 297, 337, 10.1056/NEJM197708112970617 Copur, 1995, Bone marrow aplasia and severe skin rash after a single low dose of methotrexate, Anticancer Drugs, 6, 154, 10.1097/00001813-199502000-00018 Ritch, 1984, Skin rash following therapy with mitomycin C, Cancer, 54, 32, 10.1002/1097-0142(19840701)54:1<32::AID-CNCR2820540108>3.0.CO;2-4 Williams, 1989, Hypersensitivity reaction to high-dose cytarabine, Br J Haematol, 73, 274, 10.1111/j.1365-2141.1989.tb00267.x O’Dwyer, 1989, Hypersensitivity reactions to deoxycoformycin, Cancer Chemother Pharmacol, 23, 173 Coyle, 1992, Hypersensitivity reactions to procarbazine with mechlorethamine, vincristine, and procarbazine chemotherapy in the treatment of glioma, Cancer, 69, 2532, 10.1002/1097-0142(19920515)69:10<2532::AID-CNCR2820691024>3.0.CO;2-I Rodenburg, 1990, Hypersensitivity reactions to CHIP, J Clin Oncol, 8, 1119, 10.1200/JCO.1990.8.6.1119 Birch, 1988, Allergic reaction to intravesical Adriamycin, Br J Urol, 61, 165, 10.1111/j.1464-410X.1988.tb05074.x Doll, 1992, Vascular toxicity associated with antineoplastic agents, Semin Oncol, 19, 580 Elomaa, 1984, Raynaud’s phenomenon progressing to gangrene after vincristine and bleomycin therapy, Acta Med Scand, 216, 323, 10.1111/j.0954-6820.1984.tb03811.x von Gunten, 1993, Raynaud phenomenon in three patients with acquired immune deficiency syndrome–related Kaposi sarcoma treated with bleomycin, Cancer, 72, 2004, 10.1002/1097-0142(19930915)72:6<2004::AID-CNCR2820720635>3.0.CO;2-5 Fertakos, 1992, Digital gangrene following chemotherapy for AIDS-related Kaposi’s sarcoma, Am J Med, 93, 581, 10.1016/0002-9343(92)90589-4 Toumbis-Ioannou, 1994, Chemotherapy-induced Raynaud’s phenomenon, Cleve Clin J Med, 61, 195, 10.3949/ccjm.61.3.195 Battafarano, 1995, Docetaxel (Taxotere) associated scleroderma-like changes of the lower extremities: a report of three cases, Cancer, 76, 110, 10.1002/1097-0142(19950701)76:1<110::AID-CNCR2820760117>3.0.CO;2-9 Finch, 1980, Bleomycin-induced scleroderma, J Rheumatol, 7, 651 Kim, 1996, A case of bleomycininduced scleroderma, J Kor Med Sci, 11, 454, 10.3346/jkms.1996.11.5.454 Fournier, 1997, Efficacy and tolerance of liposomal daunorubicin in Kaposi sarcoma associated with human immunodeficiency virus infection, Arch Dermatol, 133, 918, 10.1001/archderm.1997.03890430140026 Lee, 1994, Severe exfoliative dermatitis associated with hand ischemia during cisplatin therapy, Mayo Clin Proc, 69, 80, 10.1016/S0025-6196(12)61616-4 Bencini, 1985, Exfoliative dermatitis following intravesical therapy with mitomycin C, Int J Dermatol, 24, 472 Malina, 1983, Porphyria cutanea tarda caused by methotrexate and buthiopurine therapy, Z Hautkr, 58, 241 Roenigk, 1970, Estrogen-induced porphyria cutanea tarda, Arch Dermatol, 102, 260, 10.1001/archderm.1970.04000090022004 Aramburo Gonzalez, 1986, A case of porphyria after treatment with cisplatin, Med Clin (Barc), 87, 738 Bork, 1988, 422 Koehn, 1982, Unusual cutaneous reaction to dacarbazine, Arch Dermatol, 118, 1018, 10.1001/archderm.1982.01650240062025 Young, 1996, Hypersensitivity to paclitaxel manifested as a bullous fixed drug eruption, J Am Acad Dermatol, 34, 313, 10.1016/S0190-9622(96)80147-2 Giguere, 1988, Procarbazine hypersensitivity manifested as a fixed drug eruption, Med Pediatr Oncol, 16, 378, 10.1002/mpo.2950160605 Senet, 1995, Hydroxyurea-induced dermatomyositis-like eruption, Br J Dermatol, 133, 455, 10.1111/j.1365-2133.1995.tb02677.x Richard, 1989, Skin lesions simulating chronic dermatomyositis during long-term hydroxyurea therapy, J Am Acad Dermatol, 21, 797, 10.1016/S0190-9622(89)80274-9 Bahadoran, 1996, Pseudo-dermatomyositis induced by long-term hydroxyurea therapy: report of two cases, Br J Dermatol, 134, 1161, 10.1111/j.1365-2133.1996.tb07975.x Harris, 1982, Tamoxifen induced tumor regression associated with dermatomyositis, Br Med J, 284, 1674, 10.1136/bmj.284.6330.1674-a Akiyama, 1997, A case of dermatomyositis triggered by tegafur, Acta Derm Venereol (Stockh), 77, 490 Kenner, 1997, Suramin keratosis, a unique skin eruption in a patient receiving suramin for metastatic prostate cancer, J Urol, 158, 2245, 10.1016/S0022-5347(01)68218-1 Stratakis, 1994, Capillaritis (purpura simplex) associated with use of aminoglutethimide in Cushing’s syndrome, Am J Hosp Pharm, 51, 2589 Nguyen, 1993, Hydroxyurea and lower leg ulcers, Cutis, 52, 217 Daoud, 1997, Hydroxyurea dermopathy: a unique lichenoid eruption complicating long-term therapy with hydroxyurea, J Am Acad Dermatol, 36, 178, 10.1016/S0190-9622(97)70276-7 Baker, 1970, Intermittent high dose oral methotrexate therapy in psoriasis, Br J Dermatol, 82, 65, 10.1111/j.1365-2133.1970.tb02194.x Scott, 1989, Dermatologists and anabolic-androgenic drug abuse, Cutis, 44, 30 Pochi, 1974, Acne in premature ovarian failure: reestablishment of cyclic flare-ups with medroxyprogesterone acetate therapy, Arch Dermatol, 109, 556, 10.1001/archderm.1974.01630040062017 Blatt, 1993, Severe acne and hyperandrogenemia following dactinomycin, Med Pediatr Oncol, 21, 373, 10.1002/mpo.2950210513 McCraken, 1980, Systemic lupus erythematosus induced by aminoglutethimide, Br Med J, 281, 1254, 10.1136/bmj.281.6250.1254 Collins, 1989, Pancytopenia, rash, and fever caused by diethylstilbestrol used for prostate cancer, J Rheumatol, 16, 408 Yung, 1994, Drug-induced lupus, Rheum Dis Clin North Am, 20, 61, 10.1016/S0889-857X(21)00226-X Layton, 1994, Hydroxyurea-induced lupus erythematosus, Br J Dermatol, 130, 687, 10.1111/j.1365-2133.1994.tb13129.x Layton, 1994, Immunological changes in hydroxyurea-induced collagen disease, Br J Dermatol, 131, 581, 10.1111/j.1365-2133.1994.tb08565.x Levine, 1978, Mucocutaneous side effects of cancer chemotherapy, Cancer Treat Rev, 5, 67, 10.1016/S0305-7372(78)80007-3 Gottlieb, 1986, Recurrent “flare” of dermatitis herpetiformis after cytotoxic therapy for malignant lymphoma, Med J Aust, 145, 241, 10.5694/j.1326-5377.1986.tb113822.x Amer, 1982, Bullous pemphigoid after chemotherapy for choriocarcinoma, Int J Dermatol, 21, 32, 10.1111/j.1365-4362.1982.tb00485.x Pritchard, 1980, Tamoxifen therapy in premenopausal patients with metastatic breast cancer, Cancer Treat Rep, 64, 787 Hampson, 1995, Tamoxifen-induced hair colour change, Br J Dermatol, 132, 483, 10.1111/j.1365-2133.1995.tb08690.x Gauci, 1980, Changes in hair pigmentation associated with cancer chemotherapy, Cancer Treat Rep, 64, 193 Banuchi, 1974, Acanthosis nigricans following diethylstilbestrol therapy: occurrence in patients with childhood muscular dystrophy, Arch Dermatol, 109, 545, 10.1001/archderm.1974.01630040051013 Zackheim, 1996, Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: results in twenty-nine patients, J Am Acad Dermatol, 34, 626, 10.1016/S0190-9622(96)80062-4 Coltart, 1984, Severe mucocutaneous reaction to aminoglutethimide, Br J Radiol, 57, 531, 10.1259/0007-1285-57-678-531 Polsen, 1995, Acquired cutaneous adherence in patients with androgen-independent prostate cancer receiving ketoconazole and doxorubicin: medication-induced sticky skin, J Am Acad Dermatol, 32, 571, 10.1016/0190-9622(95)90339-9